Uscom Limited · ASX:UCM

Uscom — Investor Presentation (May 2006)

19 slides from Uscom's investor presentation, May 10, 2006

  1. Slide 1: USCOM, May 2006

  2. Slide 2: Developer of patented platform technology for monitoring heart function

    * Developer of patented platform technology for. accurate, non-invasive monitoring of heart function * First device is the Ultrasonic Cardiac Output Monitor | ¥ 50 sold to date this FY a v¥ New functions added ¥ Product Pipeline - OXYCOM * Hospital market * Global distribution network

  3. Slide 3: 3 major technology advancements

    v3 major technology advancements VY Further validation against gold standard - | v US FDA approval, US distributor appointed - v Regulatory approval for Japan, Korea & Taiwan oo v Direct Sales team for Australia v Sales gain traction — approaching breakeven point |

  4. Slide 4: Quarterly sales

    $0.963m $0.380m 1st Qtr 2nd Qtr 3rd Qtr

  5. Slide 5: Release next product: OXYCOM

    C] Release next product: OXYCOM OQ Achieve international recognition as a standard a O Advance argument for medical reimbursement QO Build optimum structures in US and Europe oS 2 Reach break-even point Q) Cash flow positive

  6. Slide 6: — < - aN | oo / a ce a oo oo oo /

    — < - aN | oo / a ce a oo oo oo 0 / a —

  7. Slide 7: The USCOM solution

    The USCOM salution USCOM 1A Cardiac Output Monitor oe * Non-invasive * Portable * Simple to use ° Safe and accurate * Left & Right heart * Can be operated by nurses or paramedics ° Cost-efficient — NO consumables

  8. Slide 8: Hy Z < . “ <

    Hy Z < . “ < oo - — / — a - / — a ce — oe a rrr—CC - / . SS oo ao — SS 5 oo os oS — oo oe : — a / oo : a : / a — — a ae oo : = — — —

  9. Slide 9: Laboratory precision testing and validation

    1. Laboratory based precision testing 2. Tested against Flow Probes in animals Tested against Catheters - the “gold standard”

  10. Slide 10: Studies presented at congresses in 2005

    » 28 studies presented — 24 congresses in 2005 * 4 published in peer-reviewed journals

  11. Slide 11: Emergency and paediatrics clinical use

    EMERGENCY: Now in clinical use at key sites in Aust, Asia, Europe & U.S. Collaborative study at 7 hospitals. Dr Emanuel Rivers Henry Ford Hospital, Detroit PAEDIATRICS: Now in clinical practice at 8 leading paediatrics sites. Great Ormond Street Hospital, London

  12. Slide 12: Dr Joe Brierley, Great Ormond Street Hospital

    lacO nut ps | i ne aun mi Dr Joe Brierley Great Ormond Street Hospital, London

  13. Slide 13: Market Strategy

    _ pe a ae Market Strategy

  14. Slide 14: US hospital market penetration assumptions

    * US = 5,800 hospitals * Assume 4% penetration over 3 years = 232 sites * Assume an average 3 units per site = 696 units. ° Sale rr ice of US$20, O00 (atter sates commissions) — ¢ Gross revenue = US$13,920,000 ¢ Gross revenue = A$17,846,000 * US = 33% of world market (US = Europe = Asia) — * WORLD =

  15. Slide 15: Direct sales and distributors

    Direct sales in Au PLUS US: Tri Anim Inc UK: Beaver Medical Germany: LEA Medizintechnik North Asia: Pacific Medical Systems, Hong Kong

  16. Slide 16: Unit volumes by region

    Sail MARCH 06 ° ~ UNIT VOLUMES: USA AUST North Asia Mid East Europe South Asia Other

  17. Slide 17: Gary Davey, Rob Phillips, Paul Butler

    ii | I oe i Gary Davey Rob Phillips Paul Butler (Chief Executive) (Chairman) (Chief Operating Officer) Business Science Operations

  18. Slide 18: USCOM is achieving its milestones

    * USCOM is achieving its milestones. * Building a global business — regulatory approvals 8 and sales network in place. ¢ Achieving credibility against established methods, 7 sales traction in target markets . ¢ Dynamic growth & strengthening management. : ¢ Breakeven forseeable with adequate cash. i

  19. Slide 19: USCOM Ultrasonic Cardiac Output Monitors

    ts ~ oO Scom“ Ultrasonic Cardiac Output Monitors

Uscom — Investor Presentation (May 2006) on 6ix